Mostrando 2 resultados de: 2
Population Pharmacokinetics of Intra-articular and Intravenous Administration of Tranexamic Acid in Patients Undergoing Total Knee Replacement
ArticleAbstract: Background: Tranexamic acid (TXA), an antifibrinolytic drug, is usually administered intravenously;Palabras claves:Autores:Aguilera-Roig X., Baños Lapuente V., Cánovas Martínez E., Fernández Nuñez J.A., Font Gual A., González Osuna A., González Rodriguez J.C., Jordán-Sales M., Lamas C., Ma José Martínez Zapata, Pla-Junca F., Ramirez E., Rodríguez Prieto M., Rojas L.F., Valle M., Videla S.Fuentes:scopusTopical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial
ArticleAbstract: Introduction: Tranexamic acid (TXA) is becoming widely used in orthopedic surgery to reduce blood loPalabras claves:Blood loss, Topical and intravenous tranexamic acid, Total knee arthroplasty, TransfusiónAutores:Aguilera-Roig X., Celaya F., Ferńandez J.A., González Rodriguez J.C., Hinarejos P., Jordan M., Leal J., Ma José Martínez Zapata, Monllau-García J.C., Pelfort X., Puig-Verdie L., Rodriguez-Arias A.Fuentes:scopus